Summary
A 28-year-old Senior Systems Engineer with a Bachelor's degree was denied a security clearance due to concerns under Guideline E (Personal Conduct) and Guideline H (Drug Involvement). The denial stemmed from the applicant's admitted marijuana use while holding a security clearance and providing false information on her initial June 2017 security clearance application.
Specifically, the applicant lied about her illegal drug use on the application. She also admitted to using marijuana with varying frequency from June 2016 to June 2019, which included periods while she possessed a security clearance, during college, and between employment with defense contractors A and B.
The administrative judge found that the applicant's admitted marijuana use while cleared, coupled with her submission of false information on the application, raised significant concerns regarding her reliability and trustworthiness. Her claims of misunderstanding the application questions were deemed insufficient to mitigate these concerns, leading to the denial of her security clearance eligibility.
Why the Applicant Was Denied
- The applicant admitted to using marijuana while holding a security clearance, raising concerns about her reliability and trustworthiness.
- The applicant provided false information on her initial security clearance application, undermining her credibility.
- The applicant's claims of misunderstanding regarding the application questions were not sufficient to mitigate the concerns raised.
Conditions Referenced
- AG ¶ 24raisedDrug Involvement and Substance Misuse
- AG ¶ 15raisedPersonal Conduct
Key Rule Quoted
“The protection of the national security is the paramount consideration.”
Procedural Posture
- SOR issuedSep 2, 2022
- Answer filedNov 15, 2022
- Hearing held—Decided on the written record.
- Decision dateMay 19, 2023
Cite For
- Issues of Reliability and Trustworthiness Under Guideline E
- False Information on Security Clearance Applications Under Guideline E
- Drug Involvement While Holding a Security Clearance Under Guideline H